Jerry WU, PhD
Head of investment, TusPark Holdings UK
Areas of expertise: IVD, Ophthalmology Drug and Medical Devices, Wearable Medical Devices, Dental Medical Device, Orthopedics Implant Medical Devices, Minimally Invasive Surgical Instruments, Pediatric Drug, Medical Imaging Equipment
Jerry’s career journey led him to venture capital from being a principal scientist. He brings 22+ years of experience in R&D and venture investment covering life science, digital health, biotechnology, pharmaceuticals, data science, machine learning and AI.
Jerry is the Head of Investments at TusPark Holdings (UK). TusPark UK is a science and technology service corporate with an investment arm as a venture capital and private equity group fund. TusPark UK has invested £250M+ in Cambridge since 2018 (e.g. the landmark joint venture with the Trinity College to develop and operate TusPark Cambridge Science Park), and its investment portfolio spans in the era of life science/healthcare, digital technologies (big data, AI and IoT, etc.), new material, and environmental & new energy, with a unique model of “Incubation + Investment + M&As”.
As a principal scientist, Jerry has interdisciplinary R&D experience at both pharmaceutical/biotech and academy. Jerry was leading AstraZeneca’s Health Informatics in therapeutic area of cardiovascular, renal and metabolism at Global Medicine Development Division. Previously Jerry also worked at European Bioinformatics Institute, Wellcome Trust Sanger Institute, Cambridge Institute for Medical Research, BBSRC and UK Parliamentary Office of Science and Technology.